Soviet Scientists Face Perestroika's Challenge

[Editor's note: When the democratically elected Second Congress of People's Deputies met in Moscow in December, delegates expressed frustration with the slow pace of reform. Among these frustrated delegates were scientists and academics, many of whom had been chosen by their colleagues in special elections at their institutions. Under the leadership of Vitali Goldanski, the vice director of the Institute of Chemical Physics in Moscow, they formed a reform bloc and issued a public declaration o

Written byVitali Goldanski
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

[Editor's note: When the democratically elected Second Congress of People's Deputies met in Moscow in December, delegates expressed frustration with the slow pace of reform. Among these frustrated delegates were scientists and academics, many of whom had been chosen by their colleagues in special elections at their institutions. Under the leadership of Vitali Goldanski, the vice director of the Institute of Chemical Physics in Moscow, they formed a reform bloc and issued a public declaration of their aims (see story on page 1). Goldanski, a nuclear chemist, was awarded the Lenin Prize in 1980 and was named to the prestigious post of academician in 1981. He has recently done much of his work in tunneling phenomena. Russian scientists have a long history of involvement in politics, a tradition that continues today as great political changes roil their lives and their careers. Following explanatory comments by Goldanski, the declaration is excerpted ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies